E-mail  
Home
 
AboutUs
 
Service
 
Products
 
Order Information
 
Contact us
Insert title here
Featured Products
HY-10372  |  PP121
HY-10005  |  Flavopiridol
HY-10008  |  SNS-032
HY-10087  |  Navitoclax
HY-10161  |  Tozasertib
HY-10162  |  Olaparib
HY-10180  |  MLN8054
HY-10192  |  NVP-TAE 684
HY-10193  |  AZD-1480
HY-10249  |  GSK-690693
HY-10254  |  PD0325901
HY-10355  |  AKT inhibitor VIII
HY-10358  |  MK 2206 (dihydrochloride)
HY-10997  |  PCI-32765
HY-11001  |  PHA-793887
HY-11002  |  CP-466722
HY-11007  |  GNF-2
HY-30237  |  Roscovitine
HY-50662  |  A-769662
HY-50767  |  Palbociclib
more    
Products
HY-10355

CAS:612847-09-3

612847-09-3  Technical Data: Price and Availability of  Cas No:612847-09-3

Cas : 612847-09-3 M.Wt: 551.6404
Cas : 612847-09-3 Formula: C34H29N7O
Cas : 612847-09-3 Purity: >98 %
Cas : 612847-09-3 Storage: at 20℃ 2 years
Cas : 612847-09-3 Solubility: 10 mM in DMSO
Cas : 612847-09-3 Name: AKT inhibitor VIII
USD
5mg/$100 In-stock
10mg/$150 In-stock
50mg/$450 In-stock
100mg/$650 In-stock
1g Get quote
5g Get quote
>10g Get quote
We match the lowest price on market.
We offer a substantial discount on larger orders,please
inquire via sales@chemexpress.cn
or Fax: (86)21-58955996
Inquiry for price and availability only. Please place your order via our email or fax.
Online Inquiry
 
612847-09-3  Data Sheet:
 
Introduction of 612847-09-3 :
AKT inhibitor VIII is a cell-permeable quinoxaline compound that has been shown to potently, selectively, allosterically, and reversibly inhibit Akt1, Akt2, and Akt3 activity with IC50s of 58 nM, 210 nM, and 2.12 μM, respectively. IC50 & Target: IC50: 58 nM (Akt1), 210 nM (Akt2), 2.12 μM (Akt3) In Vitro: When LnCaP cells are pretreated with AKT inhibitor VIII and then incubated with TRAIL, a dramatic increase in caspase-3 activity (6-10-fold relative to control or TRAIL alone) is observed. This sensitization of tumor cell lines with AKT inhibitor VIII is not limited to LnCaP cells as similar apoptosis induction is observed in HT29, MCF7, and A2780 cells, among others, with chemosensitizers such as camptothecin, herceptin, and doxorubicin[1]. The furanodiene-induced decrease of p-Akt and Akt expressions is enhanced by the Akt inhibitor VIII pretreatment. Furthermore, the furanodiene-induced PARP cleavage is enhanced by Akt inhibitor VIII pretreatment. The Akt inhibitor VIII shows no effect on cleaved PARP expression but decreases the p-Akt and Akt expressions[2]. AKT inhibitor VIII decreases cell viability and increases phosphatidylserine (PS) translocation to the outer leaflet of the plasma membrane, DNA fragmentation, Caspase-9 cleavage, Caspase-3 activation and PARP proteolysis in hESC lines WA01 (H1) and WA09 (H9) and in a hiPSCs cell line generated in our laboratory (FN2.1)[3]. In Vivo: Mice are dosed with AKT inhibitor VIII (50 mpk, 3 doses, ip, every 90 min) achieving plasma concentrations of 1.5-2.0 μM, and then the animals are tail vein injected with IGF to stimulate Akt phosphorylation. By IP Western, both basal and IGF stimulated Akt1 and Akt2 phosphorylation are inhibited in mouse lung, with no effect on Akt3 phosphorylation[1].
 
References on 612847-09-3 :
 

Keywords: buy AKT inhibitor VIII | AKT inhibitor VIII Supplier | purchase AKT inhibitor VIII | AKT inhibitor VIII cost | AKT inhibitor VIII manufacturer | order AKT inhibitor VIII | AKT inhibitor VIII distributor | AKT inhibitor VIII structure
buy 612847-09-3 | 612847-09-3 Supplier | purchase 612847-09-3 | 612847-09-3 cost | 612847-09-3 manufacturer | order 612847-09-3 | 612847-09-3 distributor | 612847-09-3 structure
Insert title here
 
Products are for research use only. Not for human use. We do not sell to patients.           Copyright © 2009 Haoyuan Chemexpress All Rights Reserved
ADDRESS: 6/F, No. 2 Building, No. 720,Cailun Road, Shanghai, P.R.China  
TEL:
86-21-58998590   FAX: 86-21-53700326, 86-21-58998590   E-mail: sales@chemexpress.cn